Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
07/1990
07/03/1990US4939176 Viral inactivation process
06/1990
06/28/1990WO1990006770A1 Biovaccine against svc, and production of the same
06/28/1990WO1990006759A1 A pure factor i protein and a process for producing said protein
06/27/1990EP0374817A2 Method for disrupting virus particles
06/27/1990EP0374625A2 Viral inactivation process
06/21/1990CA2006078A1 Method for disrupting virus particles
06/19/1990CA1270438A1 Influenza vaccine
06/13/1990CN1042837A Process of low-poison vaccine for infestous anaemia of horse
06/05/1990US4931393 Non-infectious mutant clone of HIV
05/1990
05/31/1990WO1990005538A1 Parvovirus capsids
05/31/1990WO1990003435A3 Nucleic acid coding for the human angiotensine conversion enzyme (ace), and its applications particularly for the in vitro diagnosis of high blood pressure
05/31/1990WO1990002803A3 Viral vaccines
05/22/1990US4926547 Method for manufacturing a modular semiconductor power device
05/17/1990WO1990002802A3 Viral nucleotide sequences
05/09/1990EP0367605A2 Continuous mammalian cell lines having monocyte/macrophage characteristics and their establishment in vitro
05/08/1990US4923805 Culturing cells capable of glycosylating proteins; gene expression dimerization
05/03/1990WO1990004638A1 Fowlpox virus promoter
05/02/1990CN1041708A Porous anodic aluminium oxide membranes
05/02/1990CA2002025A1 Continuous mammalian cell lines having monocyte-macrophage characteristics and their establishment in vitro
04/1990
04/25/1990EP0365349A1 Avipox virus promoter
04/21/1990CA2001001A1 Fowlpox virus promoter
04/19/1990WO1990004041A1 Bacterial detection by phage transduction of detectable phenotype
04/19/1990WO1990004020A1 H. saimiri-htlv-x region vector
04/11/1990EP0363123A1 Porous anodic aluminium oxide membranes
04/10/1990US4915683 Antiviral method, agents and apparatus
04/06/1990CA2000094A1 H. saimiri-htlv-x region vector
04/05/1990WO1990003435A2 Nucleic acid coding for the human angiotensine conversion enzyme (ace), and its applications particularly for the in vitro diagnosis of high blood pressure
04/04/1990EP0361182A1 Recombinant Marek's disease virus, process for preparing the same and vaccine containing the same
04/04/1990CN1041005A Post-transfusion, on-a, non-b hepatitis virus and antigens
04/03/1990CA2000056A1 Porous anodic aluminium oxide membranes
03/1990
03/28/1990EP0105364B1 Temperature sensitive reassortant viruses and a vaccine against equine influenza
03/27/1990US4912030 Antibody to retrovirus
03/27/1990US4911913 Multiple embedded nuclear polyhedrosis virus from celery looper with activity against lepidoptera
03/22/1990WO1990002809A1 Generation and selection of recombinant varied binding proteins
03/22/1990WO1990002806A1 Recombinant retroviruses with amphotropic and ecotropic host ranges
03/22/1990WO1990002803A2 Viral vaccines
03/22/1990WO1990002802A2 Viral nucleotide sequences
03/14/1990EP0357738A1 Process and device for producing viruses and viral antigens
03/08/1990WO1990002191A1 Recombinant fowlpox virus
03/08/1990WO1990002190A1 Vaccine
03/08/1990WO1990001946A1 Recombinant vaccinia virus for prevention of disease caused by flavivirus
03/07/1990EP0356739A1 Recombinant DNA, microorganism carrying said recombinant DNA, and process for producing L-amino acids by the use of said microorganism
03/06/1990CA1266446A1 Enzymatic detection of bacterial capsular polysaccharide antigens
02/1990
02/27/1990CA1266243A1 Method and cell line for continuous production of retroviruses (htlv-iii) related to aids
02/22/1990WO1990001547A1 Methods for isolating herpes virus thymidine kinase-encoding dna
02/22/1990WO1990001337A1 Vaccine
02/22/1990WO1990001336A1 Novel infectious bursal disease virus
02/22/1990WO1990001253A1 Aloe compositions and uses thereof
02/14/1990EP0354440A1 Human Papilloma virus type 57, its DNA and proteins encoded thereby
02/08/1990WO1990001062A1 PHAGE VECTOR μ SK9 FOR CONSTRUCTION OF GENOME LIBRARIES
02/07/1990EP0353851A1 Fowlpox virus non-essential regions
02/07/1990CN1039359A Ibdv production in continuous lines
02/06/1990CA1265448A1 Process for preparing hepatitis b surface antigen containing particles in novel forms which are highly immunogenic
02/06/1990CA1265447A1 Hepatitis b antigenic compositions and vaccines against hepatitis b derived therefrom
01/1990
01/31/1990EP0352835A1 IBDV production in continuous cell lines
01/25/1990WO1990000597A1 Post-transfusion, non-a, non-b hepatitis virus and antigens
01/25/1990WO1990000596A1 Method of modulating virus-host cell interactions using carbohydrates and carbohydrate derivatives
01/24/1990EP0351908A1 Live newcastle disease virus vacccines
01/24/1990EP0351901A1 Swine kidney cell culture, and its use in vaccine production
01/24/1990EP0351426A1 Process for manufacturing antigens, vaccines and sera to combat bacterial or viral diseases and composition for implementing said process
01/23/1990CA1264688A1 Pseudorabies virus mutants, vaccines containing same, methods for the production of same and methods for the use of same
01/16/1990US4894228 Vaccine against hepatitis A virus
01/10/1990EP0349594A1 Recombinant baculovirus occlusion bodies in vaccines and biological insecticides
01/10/1990EP0349583A1 Heliothis expression systems
01/10/1990CN1038668A Expression of hepatitis b and pres 2 proteins in methylotrophic yeasts
12/1989
12/28/1989WO1989012684A1 Fowlpox virus non-essential regions
12/27/1989EP0347435A1 Dna sequences, recombinant dna molecules and processes for producing soluble t4 proteins
12/27/1989CN1038306A Recombinant retroviruses
12/20/1989EP0347365A2 HIV-2 virus variants
12/20/1989EP0346430A1 Proteins and process for preparing them, dna sequences, antibodies and their application, poxvirus, transformed or infected cells and pharmaceutical compositions useful for preventing toxoplasmosis
12/14/1989WO1989012103A1 Method of selecting for recombinant pox viruses
12/14/1989WO1989012094A1 Hiv-3 retrovirus and its use
12/13/1989EP0345559A2 HIV-2 variants
12/13/1989EP0345375A1 HIV-3 retrovirus and its use
12/13/1989CN1037838A Live combination vaccine
12/12/1989US4886779 Inactivation of human immunodeficiency virus (HIV) in protein-containing solutions by phenols
12/12/1989US4886754 Ligating genetic fragments with dna, incubating with organism, selecting transformed hosts, recovering
12/06/1989EP0345152A1 Modified Baculovirus, preparation and use as an expression vector
12/06/1989EP0344864A2 Method for producing nonhyperglycosylated hepatitis B virus protein
11/1989
11/30/1989WO1989011539A1 Retroviral vector
11/28/1989CA1263305A1 Oral vaccines
11/23/1989EP0343137A1 Fibronectin binding protein
11/23/1989EP0342860A2 Novel protein, sequences containing the gene therefore, vectors, methods of preparation and use
11/23/1989EP0342564A2 Method for the production of a test antigen for the diagnosis of bovine herpes virus type 1 (BHV 1) infection
11/15/1989EP0342128A1 Papillomavirus probes (HPV49, HPV50, HPV54, HPV55), products genetically and immunologically related to this papillomavirus and in vitro methods for the diagnosis of papillomavirus infections and for the production of antibodies against these papillomaviruses
11/15/1989EP0341746A2 Expression of hepatitis B S and preS2 proteins in methylotrophic yeasts
11/15/1989EP0341444A2 Rapid mutational analysis method
11/08/1989EP0340359A1 Baculovirus transfer vectors
11/07/1989US4879236 Genetic engineering, baculovirus
11/07/1989CA1262682A1 Treatment of biological and pharmaceutical products adsorbed on a solid phase with virus and pyrogen inactivating agents
11/02/1989EP0339668A2 Hepatitis A virus antigen
11/02/1989EP0339667A2 Hepatitis A,B,-combined adjuvanted vaccine
11/02/1989EP0339569A2 Expression of the HIV 24 KDA GAG protein in methylotrophic yeasts
10/1989
10/31/1989US4877737 Attenuated pseudorabies virus which has a deletion in at least a portion of a repeat sequence and vaccine containing same
10/31/1989CA1262532A1 Composition useful for the production of vaccines containing particles with the surface antigen of the hepatitis b virus and the receptor of the polymerized human serum albumin, animal cells capable of producing such particles and process for their obtention
10/25/1989EP0338453A2 A method of sensitization of small animals to the infection of human retroviruses
10/25/1989EP0338265A2 Haemophilus influenzae type B polysaccharide-outer membrane protein conjugate vaccine
10/19/1989WO1989009816A1 Method for manipulation of the cell types of eukaryotes
10/19/1989WO1989009815A1 Novel virus of the hiv-2 family and methods of detection therefor
10/19/1989WO1989009785A1 Peptides inhibitors of hiv induced cell fusions and syncytia formation
1 ... 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267